World Journal of Surgical Oncology. Open Access. Case report .... G, Palumbo P, Nasti AG: Metastasis to the breast of a renal car- cinoma: a clinical case.
tissues and breast cancer cell lines by RT-qPCR analysis, and the expression ..... C and Jiang Y: The role of miR-506 in transformed 16HBE cells induced by.
via the bloodstream and the lymphatic system. The reason the ... Ibaraki, Japan. 1 Tsukuba Üniversitesi Mito Tıp Merkezi, Solunum Hastalıkları Anabilim Dalı,.
Dec 1, 2010 - Nancy Gavert1, Alessia Vivanti1, John Hazin1, Thomas Brabletz2, and Avri Ben-Ze'ev1 ...... Kiefel H, Bondong S, Erbe-Hoffmann N, et al.
lar mass with extension into right upper lung. Computed tomographic scan of the chest demonstrat- ed a right hilar tumor with right paratracheal and sub-.
that the proliferation rate of HT1080 human fibrosarcoma cells was significantly .... Culture Collection (ATCC, Manassas, VA, USA). Dulbecco's modified Eagle's ...
Oct 8, 2015 - Rac1/Cdc42 activity and is associated with poor prognosis. Jeng-Shou ..... with or without GIT1 overexpression into NSG mice as described above. ..... injected into NOD/Shi-scid/IL-2RÎ³null (NOG) male mice. (6â8 weeks old) ...
surface proteins of a series of related murine colon cancer cells selected in an animal ... tumors formed after cecal injection of parental 51B suggested selective.
cell cycle, Tumorigenesis. Introduction. Cancer cells differ from normal cells in many important characteristics. These include the loss of differentiation, self-.
easier than with in vivo or in vitro experiments, the in virtuo experiments can be replicated and eventually developed. Consequently, the knowledge gained ...
Nov 21, 2011 - Trousseau . The association between mucinous car- cinoma and Trousseau's syndrome led to the hypothesis that mucin might directly ...
Apr 18, 2017 - Aloe-emodin induces apoptotic cell death by oxidative stress and sustained c-Jun N-terminal kinase (JNK) activation . Previous. Hindawi. Analytical Cellular .... dark for 30min, the samples were analyzed by a flow cyt- ometer (BD .
Mar 18, 2015 - process. In describing the macrostructure and dynamics of plasma membranes .... as cell adhesion and motility, growth, endocytosis, exocytosis, .... Cytoplasm. A. B ... larger vesicles that fuse with the cell membrane.
scientist with Prof. Melvin Calvin (1961 Nobel Prize in Chemistry) of the Calvin-Benson Cycle in chloroplasts, describing the the fixation of CO2 into carbohydrate ...
A total of 78 gastric cancer tissues, as well as the adjacent non-tumor tissues .... (Thermo Fisher Scientific, Inc.) were seeded in a 96âwell plate at a density of ...
Nov 17, 2006 - hematopoiesis, can be differentiated and stimulated through the expression of cytokines, including M-CSF,. RANKL, IL-6, IL-8, and IL-11 (Boyle et al., 2003). The source for many of these factors, especially RANKL, is in fact the bone-f
Metastasis is a characteristic trait of most tumour types and the cause for the majority of cancer deaths. Many tumour types, including melanoma and breast and prostate cancers, first metastasize via lymphatic vessels to their regional lymph nodes. A
Feb 29, 2016 - Keywords: Breast cancer, cancer stem cells, mesenchymal stem cells, hematopoietic stem cells, ... Correspondence: Pranela Rameshwar, Ph.D., New Jersey Medical .... transfer of signaling molecules by exosomes have signif- ... Exosomes s
(Thermo Fisher Scientific). These samples and Bolt LDS. Sample Buffer (Thermo Fisher Scientific) and Bolt Sample. Reducing Agent were mixed and heated at ...
patients with non-small cell lung cancer (NSCLC) treated with surgery. Expression patterns ... UCP1 was significantly associated with squamous cell histology (P = 0.05), whilst UCP3 .... of the primary antibody was used as a negative control. The ant
when diagnosed at an early stage.1 However, only one third of patients with NSCLC are diagnosed at an early stage ..... Reduced lung-cancer mortality with low-dose computed tomo- ... 7. de Koning HJ, Meza R, Plevritis SK, et al. Benefits and ...
plification in SQCLC is around 20% (69). Several selective. FGFR1 tyrosine kinase inhibitors (AZD4547, BGJ398) are currently in early phases of clinical testing.
Apr 3, 2018 - Landi1, Chiara Bennati1, Michela Spreafico1, Manolo D'Arcangelo1, Valentina ...... Capodanno A, Landi L, Tibaldi C, Minuti G, Salvini J,.
CANCER CELL MEMBRANES AND METASTASIS 2012 Michael Lea
CANCER CELL MEMBRANES AND METASTASIS Lecture Outline 1. Changes at the cancer cell surface 2. Cell surface composition 3. Mucins 4 Cell 4. C ll adhesion dh i 5. Agglutinability of cancer cells 6 Surface proteolytic activity 6. 7. Increased transport 8. Secretion and shedding g from cancer cells 9. Epithelial-Mesenchymal Transition and Metastasis
CHANGES IN CANCER CELL MEMBRANES
Changes at the cell surface of cancer cells in vivo are suggested by the tendency of cancer cells to show invasion of surrounding tissues and metastasis to distant sites. The loss of contact inhibition in transformed cells in vitro also suggests cell surface changes. Neoplastic cell proliferation might be related to a number of factors: 1. Loss of feedback control between surface and nucleus 2. Presence of surface proteolytic activity 3. Loss or modification of specific surface glycoproteins and glycolipids 4. Altered nucleotide cyclase activity in the membrane 5. Increased solute transfer of essential nutrients 6. Antigen changes
CELL MEMBRANE COMPOSITION
The chief membrane components are lipids, proteins, glycoproteins, glycolipids and glycosaminoglycans. There is increased sialic acid in many human tumors but usually less sialic acid in membranes of transformed cultured cells. In many human tumors the content off cholesterol and phospholipid is higher than the corresponding normal tissues. However,, mouse and rat leukemic lymphocytes have similar amounts of cholesterol compared to normal lymphocytes. Membrane phospholipids do not vary significantly in many tumor systems compared to normal or untransformed cells, although minor shifts in fatty acid composition have been reported.
CELL MEMBRANE COMPOSITION
Cholesterol decreases the fluidity of membranes. In human leukemia and lymphoma y p cells there is increased fluidity which has been attributed to the decrease in cholesterol in the membranes or a change in the phospholipid to cholesterol ratio ratio. When cholesterol was added to leukemia cells their membrane viscosity was restored to normal. Animals injected with treated leukemia cells had longer survival i l times i than h those h iinjected j d with i h untreated d lleukemic k i cells. However, many solid tumors show normal membrane fluidityy so this change g is not a g general p phenomenon.
CELL MEMBRANE COMPOSITION
In transformed hamster fibroblasts there is ((a)) decreased d d amounts t off more complex l glycolipids l li id or deletion of terminal saccharide residues (b) inability of glycolipid synthesis to respond to cell contact with the addition of terminal saccharide sequences (c) enhanced glycolipid accessibility to antibodies, enzymes and lectins. lectins These types of changes are found in many but not all malignant cells.
MUCINS IN CANCER Mucins are large extracellular proteins that are heavily glycosylated with complex oligosaccharides. p y adenocarcinomas,, express p aberrant Cancer cells,, especially forms or amounts of mucins. The expression of distinct oligosaccharide structures, together with differential glycosylation of mucin core proteins provides an enormous range of potential ligands for interaction with other receptors at the cell surface surface. Mucins may contribute to tumor invasion by disrupting interactions between normal cells and establishing new ligands for interaction between invading cells and the adjoining cells. Two of the most widely used serum diagnostic tests for adenocarcinomas (CA19-9 and CA125) recognize epitopes that are found on mucins. Several clinical trials have targeted mucins that are expressed by adenocarcinomas including monoclonal-antibody-based therapies and tumor vaccines. Reference: M.A. M A Hollingsworth and B B.J. J Swanson Swanson, Nature Reviews Cancer 4: 45 45-60, 60 2004 2004.
CELL ADHESION AND SIGNALING BY CADHERINS AND IG-CAMS Cell-adhesion molecules mediate intercellular and cellmatrix interactions.Changes in the expression or function of these molecules can contribute to tumor p progression g by y altering g the adhesion status of the cells and by affecting cell signaling. The function of epithelial (E)-cadherin is decreased in most epithelial p tumors during g cancer p progression. g Loss of Ecadherin function elicits active signals that support tumorcell migration, invasion and metastasis. Loss of E-cadherin can be accompanied by increased level of other cadherins such as N-cadherin which promotes tumor cell motility and migration. NCAM is a member of the Ig-CAM family (immunoglobulin-like cell adhesion molecules). It is markedly down regulated in astrocytomas and in colon and pancreatic cancer and this loss is correlated with poor prognosis. Reference:U. Cavallaro ad G. Christofori, Nature Reviews Cancer 4:118, 2004.
DELETION OF FOCAL ADHESION KINASE Loss of cellular focal adhesions is crucial to the development and progression of invasive cancer. Specific deletion of focal adhesion kinase has been shown to suppress tumor formation and block malignant progression Reference: McLean GW et al., Genes Dev. Dec. 2004.
INTEGRINS Integrins are a group of transmembrane proteins that form dimers by the association of alpha and beta subunits. They y are involved in signal g transduction across the cell membrane. Extracellular matrix components bind to the integrins and initiate an intracellular signaling cascade that results in the formation of a focal adhesion complex consisting of cytoskeletal and signal transduction molecules. Some integrins are expressed constitutively and others such as v3 and 51 are expressed by host endothelial cells only when activated as in wound healing and more pathological states such as angiogenesis, solid tumor growth, diabetic retinopathy and rheumatoid arthritis. Tumor formation and progression can be associated with an altered pattern of integrins.
Integrins can act to localize proteases such as matrix metalloproteinases (MMPs) to the leading edge of the cell to support migration and invasion. The majority of MMPs may be produced by fibroblast cells associated with tumor cells. This expression pattern may be related to a tumor cell surface glycoprotein named extracellular matrix metalloproteinase ind cer (EMMPRIN) inducer (EMMPRIN). The expression e pression of EMMPRIN in breast cancer correlates with tumor size and staging and is predictive of poor prognosis.
Most tumor or transformed cells agglutinate in the presence of lectins at much lower concentrations than their untransformed counterparts. The major agents studied have been wheat germ agglutinin and concanavalin A. High g saturation densities during g in vitro cell g growth are generally indicative of elevated tumorigenicity and for many cells their lectin agglutination properties directly follow their ability to grow to high densities in vitro. Normal and transformed cells differ not in the number of receptors but in their distribution according to most workers although increased numbers have been reported. Nicolson suggested that lectin binding will be affected by: a. saccharide binding constant b. number of binding sites c. net charge g d. size.
In normal o a ce cells s tthere e e is s less ess su surface ace mobility ob ty o of tthe e receptors ecepto s as shown with ferritin-labeled concanavalin A. There is a greater concentration in cancer cells (capping) as opposed to the random distribution in normal cells. Hynes proposed that outer surface peripheral components such as fibronectin, which is lost or reduced on transformation, may control the mobility of surface glycoproteins and therefore regulate cell agglutination properties. Fibronectin is a glycoprotein and was originally described as a l large, external, t l ttransformation f ti sensitive iti (LETS) protein. t i Nicolson suggested that a change in one or more of the cell surface restraint systems (microtubules, microfilaments and thick filaments) is the most probable cause of altered mobility of surface components and can be blocked by drugs such as colchicine, and vinblastine. i bl ti
SURFACE PROTEOLYTIC ACTIVITY Increased p proteolytic y activity y at the surface of cancer cells does not by y itself trigger the neoplastic transformation. During mitosis normal cells decrease in adhesive nature. Surface proteolytic activity by plasminogen activator, a serine protease, favors the conversion of plasminogen to plasmin. A variety of proteolytic enzymes including collagenase have been reported to increase in activity activity. The release of several enzymes by tumor cells has been attributed to leaky membranes. These include glycolytic enzymes, cathepsins, collagenases and plasminogen p g activator. The fibrinolytic y activity y of tumor cells appears pp to arise from the plasminogen activator. Viral transformation of chick embryo fibroblasts is accompanied by increased release of plasminogen activator which can be detected before morphologic change. Transformation of rodent fibroblasts also increases fibrinolytic activity activity. Reich and coworkers showed that the prominent fibrinolysis of neoplastic cells depend upon: a. the presence of normal serum plasminogen b release of plasminogen activator from neoplastic cells b. cells. SV40-transformed cells show a greater migration rate on a solid medium than normal cells this rate depend strongly on the availability of plasminogen.
SURFACE PROTEOLYTIC ACTIVITY The plasminogen activators are serine proteases inhibited by diisopropylphosphofluoride p py p p with an arginine g specificity. p y When normal cells are co-cultivated with transformed cells,the normal cells take on the morphology of transformed cells by rounding up and multilayering. Exposure of normal cells to plasmin can also cause these changes. Density dependent modulations of release of plasminogen activator as seen with normal fibroblasts do not occur in transformed cells. Release of hydrolases y by y tumor cells mayy 1. cause destruction of normal tissues and facilitate infiltration 2. release nutrients from normal cells 3 interfere with normal surface recognition 3. 4. alter antigenic properties of cancer cells.
Release R l off urokinase ki plasminogen l i activator (uPA) and the activation of extracellular proteins
INCREASED TRANSPORT Transformation is often accompanied by increased transport of glucose,amino acids, phosphate and uridine. The best evidence for increased transport of nutrients has been observed with cultured cells. cells After transformation of mammalian or avian fibroblasts by oncogenic DNA or RNA viruses there is increased hexose uptake uptake. Studies with temperature sensitive viral mutants indicate that oncogenic conversion rather than the presence of the viral genome is necessary for the changes in metabolite transport. This is further supported by observations that neoplastic transformation by SV40 virus i d induces alterations lt ti iin sugar and d amino i acid id ttransportt prior i tto llysis. i M More th than one mechanism may operate. Oncogenic transformation with DNA viruses caused a three-fold increase in Vmax for 2-deoxy-D-glucose in chick embryo fibroblasts produced a 10-20 fold decrease in Km. whereas murine sarcoma viruses p
INCREASED TRANSPORT Amino acid transport has been studied most extensively with the nonmetabolizable amino acid analog alpha-aminoisobutyrate and cycloleucine. Neoplastic transformation of mouse or hamster fibroblasts by DNA viruses increased the Vmax by a factor of 2-3. No change g in Km was observed. Changes g in Km would be more significant g for amino acid uptake than for glucose. The circulating glucose concentration (about 5 mM) is considerably above the Km for glucose transport in both normal and transformed cells. However, the plasma concentrations of essential amino acids (0.02-0.2 mM) are well below the Km values for amino acid transport into cells cells. Not all changes in neoplasia indicate increased uptake of metabolites. Kelley and Potter found primary hepatomas in rats can have decreased uptake of alphaaminoisobutyrate. Decreased orotate uptake occurs in liver and kidney tumors. In the case of amino acids it is the A system for small neutral amino acids which tends to show increased activity while the L system is unchanged. If cancer cells had typical junctions with normal cells the relative advantage of increased metabolite uptake would be diminished. It has been suggested that there maybe a failure in junctional communication in cancer cells that permits levels of metabolites to be attained which act as a signal for cell division.
SECRETION AND SHEDDING FROM CANCER CELL SURFACES
It has long been suggested that cancer cells may secrete growth promoting polypeptides. In addition to being mitogens these polypeptides might cause morphological changes h and d anchorage-independent h i d d t growth th and d th the lloss off density-dependent inhibition of growth. Receptors for the polypeptides would be on the cell surface. Sporn and Todaro proposed the term autocrine secretion for this type of self stimulation. They called the polypeptides “transforming transforming growth factors” factors (TGFs). (TGFs) TGFs have been isolated from the medium of cultured mouse and human tumor cell lines. They are of relatively low molecular weight (6,000 to 20,000 daltons). They are acid stable and inactivated by dithiothreitol. More recent work has shown that oncogene products can be g p growth factors or modified g growth factor receptors.
SECRETION AND SHEDDING FROM CANCER CELL SURFACES
Secretion implies exocytosis but many cell-surface cell surface components can be lost by simple shedding. It has been suggested that the release from malignant cells of molecules such h as fib fibronectin ti or certain t i glycosaminoglycans l i l may b be responsible for the loss of adhesion which characterizes cancer cells. In some animal models, cells from the most malignant and d mostt rapidly idl metastasizing t t i i ttumors h had d th the lleastt amountt off glycocalyx due to continuous shedding. Furthermore the g may y reduce the cell’s release of cell-surface tumor antigens vulnerability to immune attack.
Events in the metastatic process In about two thirds of patients cancer has already metastasized at the time of diagnosis. Metastasis requires a series of events: 1. Disruption of the basement membrane 2 Cell detachment 2. 3. Cell motility 4 Invasion 4. 5. Penetration of the vascular sytem 6. Survival in the circulation 7. Arrest (stasis) 8. Extravasation and proliferation Reference: McKinnell et al., The Biological Basis of Cancer, p. 53 (1998)
Up to 60% of patients with invasive cancer have overt or occult metastases at diagnosis. A Acquisition i iti off th the iinvasive i phenotype h t iis an early l eventt iin cancer progression. Millions of tumor cells are shed daily into the circulation. Less than 0 0.01% 01% of circulating tumor cells successfully initiate a metastatic focus. Angiogenesis is a ubiquitous and early event that is necessary for and p promotes metastatic dissemination. Invasion and angiogenesis use the same signal transduction programs and gene expression cassettes. Circulating tumor cells can be detected in patients who do not develop overt metastatic disease. Metastases may be as susceptible to anticancer therapy as their primary tumors. Therapeutic intervention against targets off invasion and metastasis may alter both the metastatic process and angiogenesis.
Metastasis may require a change of phenotype known as the E ith li l M Epithelial-Mesenchymal h lT Transition iti
Nm23 GENE Some types of cancer such as melanoma are highly metastatic. Others, such as ovarian cancer have a much lower tendency to metastasize metastasize. Expression of the nm23 gene has been found to be highly expressed in normal tissues but has an inverse relationship with the tendency to metastasize in melanoma cell lines. Reference: McKinnel et al., The Biological Basis of Cancer, p.68-70 (1998)
Metastasis-associated proteins (MTAs) MTA1 is one of the most commonly overexpressed gene products in human cancers. The mechanism involved has been p proposed p to be either transcriptional regulation, postranslational modification or both. Overexpression p of MTA1 was able to confer an anchorage-independent phenotype to a noninvasive breast cancer cell line. Some actions of MTA1 are believed to arise because it is a component of the nucleosome remodeling and histone deacetylase (NuRD)complex. MTA1 regulates g multiple p oncogenes g and may y a “regulator of regulators” of transformation. Reference:D-Q. Li et al., Metastasis-associated p protein 1/nucleosome remodeling g and histone deacetylase complex in cancer. Cancer res. 72: 387-394, 2012
Tumor sublines can be selected with preferred target organs for metastasis. Three mouse melanoma lines derived from B16 tumor cells, which preferentially colonized lung, brain and d th the ovaries, i h had d a diff differentt pattern tt off surface f proteins. t i In I general the amount (or the accessibility) of these specific surface proteins increased with the cell’s metastatic potential. Oncogene and tumor suppressor genes have been identified that either increase or decrease metastasis, respectively. Thus the nm23 protein is an inhibitor of metastasis and low levels of the protein in breast cancer have been associated with metastasis and poor survival.
The matrix metalloproteinases (MMPs) appear to exert a number of roles from regulation of tumor growth through intravasation and extravasation and growth in a metastatic site. it Th These proteases t include i l d th three major j groups: collagenases degrading fibrillar collagen, stromelysins acting on proteoglycans and glycoproteins and gelatinases degrading nonfibrillar and denatured collagens. There are tissue inhibitors of metalloproteinases (TIMPs) whose activities inhibit metastasis. metastasis
References Chambers, A.F. and Matrisian, L.M., Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst., 89: 1260-1270, 1997. Price, J.T., Bonovich, M.T., and Kohn, E.C., The biochemistry of cancer dissemination. Crit. Rev. Biochem. Mol. Biol., 32: 175253, 1997
Primary tumors and their metastatic tropisms
CANCER CELL MEMBRANES AND METASTASIS SUGGESTED READING E.C. Kohn, In Holland-Frei Cancer M di i - 8th Ed, Medicine Ed Part P t II, II Section S ti 1, 1 10. 10 Invasion and Metastases (20010). R.W. Ruddon and D.W. Kufe, In HollandFrei Cancer Medicine - 8th Ed, Part II, S i 1, Section 1 9. 9 Bi Biochemistry h i off Cancer C (2010). R.A Weinberg, The Biology of Cancer, Chapter 14, Garland Press, 2007.